Skip to NavigationSkip to content

Payment changes of authority's fees in France

Published date: 
20/01/2012

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no longer payable to the French regulatory authority, but will become payable to the State.  Implementation of the arrangements is expected shortly and in the meantime transitional arrangements apply.  National fee rules for Marketing Authorisation Applications (MAAs) and other regulatory procedures can be complex with different authorities having their own national sets of rules to interpret; as with France, these rules may also change from time to time and fee reviews take place at different times of the year in different countries.  Expert advice helps avoid inadvertent overpayments, and also underpayments which may delay validation and procedure start dates.

With its network of local regulatory advisors, Wainwright Associates is pleased to advise on and organise fee payments in nearly 65 countries on behalf of its clients.  If we can help, please contacts us on +44 (0)1628 530554 or email enquiries@wainwrightassociates.co.uk.

 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches